comparemela.com

Page 4 - Med Systems News Today : Breaking News, Live Updates & Top Stories | Vimarsana

12 Health Care Stocks Moving In Tuesday s After-Market Session

Gainers Lixte Biotech Holdings (NASDAQ:LIXT) shares moved upwards by 16.45% to $3.75 during Tuesday’s after-market session. Today’s trading volume for this security ended up closing at 1.0 million shares, which is 100.31 percent of its average volume over the last 100 days. The company’s market cap stands at $51.2 million. Repro-Med Systems (NASDAQ:KRMD) shares moved upwards by 6.45% to $4.45. Trading volume for this security closed at 4.8K, accounting for 1.34% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $197.9 million. As per the news, the Q1 earnings report came out 4 days ago. Midatech Pharma (NASDAQ:MTP) stock rose 5.31% to $2.18. Trading volume for this security closed at 1.7K, accounting for 0.47% of its average full-day volume over the last 100 days. The company’s market cap stands at $27.6 million.

Bragar Eagel & Squire, P C Reminds Investors That Class Action Lawsuits Have Been Filed Against Peloton, Repro Med, and ChemoCentryx and Encourages Investors to Contact the Firm

Home / Top News / Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Peloton, Repro Med, and ChemoCentryx and Encourages Investors to Contact the Firm Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Peloton, Repro Med, and ChemoCentryx and Encourages Investors to Contact the Firm NEW YORK, May 13, 2021 (GLOBE NEWSWIRE) Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Peloton Interactive, Inc. (NASDAQ: PTON), Repro Med Systems, Inc. d/b/a KORU Medical Systems (NASDAQ: KRMD), and ChemoCentryx, Inc. (NASDAQ: CCXI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.